Clinical Trials Browser

Phase 1/2 × Neuroendocrine Tumors × Al18F-NOTA-octreotide × Clear all

NCT03511768 2018-04-30

A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms

Phase 1/2 Unknown

Neuroendocrine Tumors